Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sci. Signal., 1 February 2011
Vol. 4, Issue 158, p. ra6
[DOI: 10.1126/scisignal.2001249]
RESEARCH ARTICLES
Editor's Summary
β-Catenin for Gluconeogenesis
In the canonical Wnt signaling pathway, binding of Wnt ligands to receptors stabilizes β-catenin, leading to the initiation of gene transcription by β-catenin in the nucleus. The role of the Wnt signaling pathway has been well established in developmental processes; however, growing evidence also implicates this pathway in the regulation of metabolism. Liu et al. found that hepatic deletion of β-catenin in mice decreased gluconeogenesis (the process by which the liver produces glucose) and serum glucose concentrations. More β-catenin interacted with the transcription factor FoxO1 (which is involved in transcriptional responses to insulin signaling) in hepatocytes from starved compared to fed mice, an interaction that promoted the transcriptional activation of genes encoding gluconeogenic enzymes. In obese mice, hepatic deletion of β-catenin improved overall glucose tolerance and reduced hepatic gluconeogenesis. Thus, therapies that target β-catenin function in the liver could be used to treat metabolic diseases such as diabetes.
Citation: H. Liu, M. M. Fergusson, J. J. Wu, I. I. Rovira, J. Liu, O. Gavrilova, T. Lu, J. Bao, D. Han, M. N. Sack, T. Finkel, Wnt Signaling Regulates Hepatic Metabolism. Sci. Signal.4, ra6 (2011).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Wei Wong (12 February 2013) Sci. Signal.6 (262), ec41.
[DOI: 10.1126/scisignal.2004055] |Abstract »
MEETING REPORTS
Folkert Verkaar, Ken M. Cadigan, and Renée van Amerongen (11 December 2012) Sci. Signal.5 (254), mr2.
[DOI: 10.1126/scisignal.2003714] |Abstract »|Full Text »|PDF »
EDITORS' CHOICE
John F. Foley (17 April 2012) Sci. Signal.5 (220), ec113.
[DOI: 10.1126/scisignal.2003141] |Abstract »
EDITORS' CHOICE
Wei Wong (20 March 2012) Sci. Signal.5 (216), ec82.
[DOI: 10.1126/scisignal.2003052] |Abstract »
EDITORS' CHOICE
Wei Wong (15 November 2011) Sci. Signal.4 (199), ec316.
[DOI: 10.1126/scisignal.4199ec316] |Abstract »
EDITORIAL GUIDES
Wei Wong (7 December 2010) Sci. Signal.3 (151), eg12.
[DOI: 10.1126/scisignal.3151eg12] |Abstract »|Full Text »|PDF »
EDITORS' CHOICE
Paula A. Kiberstis (27 July 2010) Sci. Signal.3 (132), ec229.
[DOI: 10.1126/scisignal.3132ec229] |Abstract »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
The Wnt Signaling Pathway Effector TCF7L2 Controls Gut and Brain Proglucagon Gene Expression and Glucose Homeostasis.
W. Shao, D. Wang, Y.-T. Chiang, W. Ip, L. Zhu, F. Xu, J. Columbus, D. D. Belsham, D. M. Irwin, H. Zhang, et al. (2013)
Diabetes
62, 789-800
|Abstract »|Full Text »|PDF »
WISP2 regulates preadipocyte commitment and PPAR{gamma} activation by BMP4.
A. Hammarstedt, S. Hedjazifar, L. Jenndahl, S. Gogg, J. Grunberg, B. Gustafson, E. Klimcakova, V. Stich, D. Langin, M. Laakso, et al. (2013)
PNAS
110, 2563-2568
|Abstract »|Full Text »|PDF »
Genome-wide analysis of FoxO1 binding in hepatic chromatin: Potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis.
D.-J. Shin, P. Joshi, S.-H. Hong, K. Mosure, D.-G. Shin, and T. F. Osborne (2012)
Nucleic Acids Res.
40, 11499-11509
|Abstract »|Full Text »|PDF »
The Wnt signaling pathway effector TCF7L2 is upregulated by insulin and represses hepatic gluconeogenesis.
W. Ip, W. Shao, Y.-t. A. Chiang, and T. Jin (2012)
Am J Physiol Endocrinol Metab
303, E1166-E1176
|Abstract »|Full Text »|PDF »
Wnt/Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism.
S. Y. Lee, H. M. Jeon, M. K. Ju, C. H. Kim, G. Yoon, S. I. Han, H. G. Park, and H. S. Kang (2012)
Cancer Res.
72, 3607-3617
|Abstract »|Full Text »|PDF »
Low Density Lipoprotein (LDL) Receptor-related Protein 6 (LRP6) Regulates Body Fat and Glucose Homeostasis by Modulating Nutrient Sensing Pathways and Mitochondrial Energy Expenditure.
W. Liu, R. Singh, C. S. Choi, H.-Y. Lee, A. R. Keramati, V. T. Samuel, R. P. Lifton, G. I. Shulman, and A. Mani (2012)
J. Biol. Chem.
287, 7213-7223
|Abstract »|Full Text »|PDF »
Liver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosis.
Y. Liu, D. Zhou, F. Zhang, Y. Tu, Y. Xia, H. Wang, B. Zhou, Y. Zhang, J. Wu, X. Gao, et al. (2012)
J. Lipid Res.
53, 358-367
|Abstract »|Full Text »|PDF »